Intravenous Infusions Limited reported financial results for the period ended June 30, 2016. For the period, the company reported revenue of GHS 4,781,354 against GHS 2,923,740 a year ago. Operating profit was GHS 817,815 compared to operating loss of GHS 1,008,774 a year ago. Net profit before tax was GHS 596,981 compared to loss of GHS 1,270,608 a year ago. Net profit for the year was GHS 485,047 against loss of GHS 1,270,608 a year ago. Net from operating activities was GHS 4,670,417 compared to net cash used in operating activities of GHS 1,004,848 a year ago. Purchase of property, plant and equipment was GHS 361,382 compared to GHS 30,977 a year ago.